Accueil > Actualité > Société

GE: collaboration with optellum in lung cancer

( - GE Healthcare, a specialist in medical imaging solutions, and Optellum, a specialist in AI-based decision support for the early diagnosis and optimal treatment of lung cancer, today announced that they have signed a letter of intent to collaborate on advancing the precision diagnosis and treatment of lung cancer.

The companies seek to address one of the biggest challenges in lung cancer diagnosis - helping providers determine the malignancy of a lung nodule.
By combining their solutions, both partners believe they can create precision healthcare.

GE's extensive clinical network can accelerate the deployment of the Optellum platform and could enable a revolutionary redefinition of early lung cancer treatment for clinicians and patients worldwide, GE's partner Optellum said.

Copyright (c) 2021 All rights reserved.





A quel niveau sera le CAC40 à fin Mars 2022:

En hausse à 7550Pts
En hausse à 7420Pts
Stable sur le niveau des 7290Pts
En baisse à 7060Pts
En baisse à 6730Pts
Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.